This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Folkesson, J. Articles by Gunnarsson, U. Search for Related Content PubMed PubMed Citation Articles by Folkesson, J. Articles by Gunnarsson, U. Social Bookmarking                            What's this?

Swedish Rectal Cancer Trial: Long Lasting Benefits From Radiotherapy on Survival and Local Recurrence Rate

From the Departments of Surgical Sciences and Oncology, Radiology, and Clinical Immunology, Uppsala University Hospital, Uppsala; and Departments of Surgery and Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden

Address reprint requests to Joakim Folkesson, MD, Department of Surgery, Uppsala University Hospital, 751 85 Uppsala, Sweden; e-mail: joakim.folkesson{at}surgsci.uu.se

PURPOSE: To evaluate the long-term effects on survival and recurrence rates of preoperative radiotherapy in the treatment of curatively operated rectal cancer patients.

PATIENTS AND METHODS: Of 1,168 randomly assigned patients in the Swedish Rectal Cancer Trial between 1987 and 1990, 908 had curative surgery; 454 of these patients had surgery alone, and 454 were administered preoperative radiotherapy (25 Gy in 5 days) followed by surgery within 1 week. Follow-up was performed by matching against three Swedish nationwide registries (the Swedish Cancer Register, the Hospital Discharge Register, and the Cause of Death Register).

RESULTS: Median follow-up time was 13 years (range, 3 to 15 years). The overall survival rate in the irradiated group was 38% v 30% in the nonirradiated group (P = .008). The cancer-specific survival rate in the irradiated group was 72% v 62% in the nonirradiated group (P = .03), and the local recurrence rate was 9% v 26% (P < .001), respectively. The reduction of local recurrence rates was observed at all tumor heights, although it was not statistically significant for tumors greater than 10 cm from the anal verge.

CONCLUSION: Preoperative radiotherapy with 25 Gy in 1 week before curative surgery for rectal cancer is beneficial for overall and cancer-specific survival and local recurrence rates after long-term follow-up.

Supported by grant No. 1921-B01-19XAC from the National Cancer Institute (Sweden).

Authors' disclosures of potential conflicts of interest are found at the end of this article.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				B. Glimelius, J. Oliveira, and On behalf of the ESMO Guidelines Working Group Rectal cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up Ann. Onc., May 1, 2009; 20(suppl_4): iv54 - iv56. [Full Text] [PDF]

				D. Papamichael, R. Audisio, J.-C. Horiot, B. Glimelius, J. Sastre, E. Mitry, E. Van Cutsem, M. Gosney, C.-H. Kohne, and M. Aapro Treatment of the elderly colorectal cancer patient: SIOG expert recommendations Ann. Onc., January 1, 2009; 20(1): 5 - 16. [Abstract] [Full Text] [PDF]

				R. C. Dresen, M. J. Gosens, H. Martijn, G. A. Nieuwenhuijzen, G.-J. Creemers, A. W. Daniels-Gooszen, A. J. van den Brule, H. A. van den Berg, and H. J. Rutten Radical Resection After IORT-Containing Multimodality Treatment is the Most Important Determinant for Outcome in Patients Treated for Locally Recurrent Rectal Cancer Ann. Surg. Oncol., July 1, 2008; 15(7): 1937 - 1947. [Abstract] [Full Text] [PDF]

				J. D. Harrison, M. J. Solomon, J. M. Young, A. Meagher, P. Butow, G. Salkeld, G. Hruby, and S. Clarke Patient and Physician Preferences for Surgical and Adjuvant Treatment Options for Rectal Cancer Arch Surg, April 1, 2008; 143(4): 389 - 394. [Abstract] [Full Text] [PDF]

				S. H. Lee, K. C. Lee, J. H. Choi, J. H. Oh, J.-H. Baek, S. H. Park, and D. B. Shin Chemoradiotherapy Followed by Surgery in Rectal Cancer: Improved Local Control Using a Moderately High Pelvic Radiation Dose Jpn. J. Clin. Oncol., February 8, 2008; (2008) hym164v1. [Abstract] [Full Text] [PDF]

				I. J. Park, H. C. Kim, C. S. Yu, T. W. Kim, S. J. Jang, and J. C. Kim Effect of Adjuvant Radiotherapy on Local Recurrence in Stage II Rectal Cancer Ann. Surg. Oncol., February 1, 2008; 15(2): 519 - 525. [Abstract] [Full Text] [PDF]

				C. Aschele and S. Lonardi Multidisciplinary treatment of rectal cancer: medical oncology. Ann. Onc., November 1, 2007; 18(11): 1908 - 1915. [Full Text] [PDF]

				J.-C. Horiot Radiation Therapy and the Geriatric Oncology Patient J. Clin. Oncol., May 10, 2007; 25(14): 1930 - 1935. [Abstract] [Full Text] [PDF]

				H. Birgisson, L. Pahlman, U. Gunnarsson, and B. Glimelius Adverse Effects of Preoperative Radiation Therapy for Rectal Cancer: Long-Term Follow-Up of the Swedish Rectal Cancer Trial J. Clin. Oncol., December 1, 2005; 23(34): 8697 - 8705. [Abstract] [Full Text] [PDF]